Brookline Capital Markets Reiterates Buy Rating on Intellia Therapeutics (NTLA)

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/10/2026

1. SPY
2. USO
3. NET
4. ORCL
5. SPCX
6. SAIL
7. SJM
8. ETR
9. AMZN
10. MU

Go back to Brookline Capital Markets Reiterates Buy Rating on Intellia Therapeutics (NTLA)
(NASDAQ: NTLA) Delayed: 12.20 -0.69 (5.35%)
Previous Close $12.89    52 Week High $30.40 
Open $12.71    52 Week Low $11.86 
Day High $13.14    P/E N/A 
Day Low $12.19    EPS $0.00 
Volume 3,959,475